These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Octreotide reduces hepatic, renal and breast cystic volume in autosomal-dominant polycystic kidney disease.
    Author: Peces R, Cuesta-López E, Peces C, Pérez-Dueñas V, Vega-Cabrera C, Selgas R.
    Journal: Int Urol Nephrol; 2011 Jun; 43(2):565-9. PubMed ID: 20449653.
    Abstract:
    A 43-year-old woman with autosomal-dominant polycystic kidney disease (ADPKD) received octreotide for 12 months, and this was associated with a 6.3% reduction in liver volume, an 8% reduction in total kidney volume and stabilization of renal function. There was also a reduction of cyst size in fibrocystic disease of breast. These data suggest that the cyst fluid accumulation in different organs from patients with ADPKD is a dynamic process which can be reversed by octreotide. This is the first report of a case of simultaneous reduction in hepatic, renal and breast cystic volume with preservation of renal function in a patient with ADPKD receiving octreotide.
    [Abstract] [Full Text] [Related] [New Search]